Financial Survey: DaVita HealthCare Partners (DVA) & The Competition
DaVita HealthCare Partners (NYSE: DVA) is one of 50 publicly-traded companies in the “Healthcare Facilities & Services” industry, but how does it compare to its competitors? We will compare DaVita HealthCare Partners to similar businesses based on the strength of its valuation, dividends, risk, analyst recommendations, earnings, profitability and institutional ownership.
Valuation and Earnings
This table compares DaVita HealthCare Partners and its competitors gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|DaVita HealthCare Partners||$15.01 billion||$2.45 billion||9.62|
|DaVita HealthCare Partners Competitors||$5.43 billion||$855.44 million||37.15|
DaVita HealthCare Partners has higher revenue and earnings than its competitors. DaVita HealthCare Partners is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Volatility & Risk
DaVita HealthCare Partners has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, DaVita HealthCare Partners’ competitors have a beta of 1.01, indicating that their average stock price is 1% more volatile than the S&P 500.
This is a breakdown of recent ratings for DaVita HealthCare Partners and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|DaVita HealthCare Partners||2||6||2||0||2.00|
|DaVita HealthCare Partners Competitors||190||1294||1831||32||2.51|
DaVita HealthCare Partners currently has a consensus price target of $65.00, indicating a potential upside of 4.00%. As a group, “Healthcare Facilities & Services” companies have a potential downside of 4.71%. Given DaVita HealthCare Partners’ higher probable upside, equities research analysts clearly believe DaVita HealthCare Partners is more favorable than its competitors.
Insider & Institutional Ownership
82.8% of DaVita HealthCare Partners shares are owned by institutional investors. Comparatively, 74.5% of shares of all “Healthcare Facilities & Services” companies are owned by institutional investors. 2.0% of DaVita HealthCare Partners shares are owned by company insiders. Comparatively, 13.1% of shares of all “Healthcare Facilities & Services” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
This table compares DaVita HealthCare Partners and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|DaVita HealthCare Partners||8.68%||14.02%||3.78%|
|DaVita HealthCare Partners Competitors||6.86%||0.47%||0.55%|
DaVita HealthCare Partners beats its competitors on 7 of the 13 factors compared.
DaVita HealthCare Partners Company Profile
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.
Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.